AstraZeneca saw the highest growth of 1.35% in patent filings and 1.27% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.35% and grants by 1.27%. GlobalData’s DataBook provides a comprehensive analysis of AstraZeneca‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
AstraZeneca has been focused on protecting inventions in United States(US) with 71 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 19% filings and 19% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where AstraZeneca is filings its patents. Among the top granted patent authorities, AstraZeneca has 19% of its grants in United States(US), 11% in Australia(AU) and 9% in European Patent Office(EPO).
Roche and Johnson & Johnson could be the strongest competitors for AstraZeneca
In terms of grant share, AstraZeneca stands in sixth position among its competitors. Roche and Johnson & Johnson secured the top positions according to recent patent publication data.
Patents related to rare diseases and nanomedicine lead AstraZeneca's portfolio
AstraZeneca has the highest number of patents in rare diseases followed by, nanomedicine and climate change. For rare diseases, nearly 56% of patents were filed and 46% of patents were granted in Q2 2024.
Chronic obstructive pulmonary disease (copd) related patents lead AstraZeneca portfolio followed by asthma, and leukemia
AstraZeneca has highest number of patents in chronic obstructive pulmonary disease (copd) followed by asthma, leukemia, rheumatoid arthritis, and breast cancer. For chronic obstructive pulmonary disease (copd), nearly 3% of patents were filed and 3% of patents were granted in Q2 2024.
For comprehensive analysis of AstraZeneca's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
